Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

UConn advances microneedle vaccine technology

Researchers in the UConn Department of Biomedical Engineering —a shared department between the UConn Schools of Dental Medicine, Medicine, and Engineering—have unlocked a new strategy using sugar...

| By Kelley Gipson

Rallybio revs up antibody discovery activities

Rallybio has become the latest company to hitch its antibody drug development efforts to AbCellera. The partners will co-develop up to five rare disease therapeutic targets...

| By Kelley Gipson

BioCT’s 9th Annual Signature Holiday Event!

We are excited to be back in person for the largest industry networking event in the state! Join the celebration and congratulate the 2022 Entrepreneur of the...

| By Kelley Gipson

FiercePharma’s ‘Fiercest Women in Life Sciences’

Here is this year’s list from FiercePharma of the 20 fiercest women in life sciences. Female representation remains depressingly low in the highest offices of the pharma,...

| By Kelley Gipson

Weekly Roundup – December 1, 2022 

View this email in your browser Weekly Roundup – December 1, 2022  The 2022 Marcum Year-End Tax Guide provides an overview of many of the issues affecting...

| By Kelley Gipson

BioXcel launches trial re bipolar, schizophrenia drug

New Haven-based BioXcel Therapeutics has begun treating patients in a trial of its drug designed to treat agitation associated with bipolar disorder and schizophrenia. Dr. Robert Risinger, chief...

| By Kelley Gipson

Prescription drug prices lagging inflation

Here’s a message from BIO about drug prices. The latest health sector economic indicators from Altarum demonstrate that healthcare prices continue to grow slower than inflation—and prescription...

| By Kelley Gipson

Bio-Techne opens new facility in Wallingford

Bio-Techne has opened a new 52,000-square-foot production and manufacturing facility in Wallingford, doubling the size of its existing facility. The expansion increases the company’s production capacity...

| By Kelley Gipson

Torigen raises funds for pet cancer vaccine

Torigen Pharmaceuticals, a commercial-stage animal health company in Farmington, has closed on a $13 million round of venture capital financing. Ashley Kalinauskas, CEO and co-founder...